Cargando…
Effectiveness and adverse drug reactions of levetiracetam and midazolam in refractory neonatal seizure: A cross-sectional comparative study
BACKGROUND: Neonatal seizure (NS) reflects serious underlying brain injury, requiring immediate evaluation and early treatment. In neonates, phenobarbitone and phenytoin are used primarily to control the seizures. If uncontrolled, widespread off-label use of midazolam and levetiracetam was practiced...
Autores principales: | Jayswal, Diptiman, Roy, Uttam Kumar, Ghosh, Taraknath, Mandal, Purnendu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150062/ https://www.ncbi.nlm.nih.gov/pubmed/34084865 http://dx.doi.org/10.4103/jehp.jehp_937_20 |
Ejemplares similares
-
Oral Levetiracetam as Add-On Therapy in Refractory Neonatal Seizures
por: MOLLAMOHAMMADI, Mohsen, et al.
Publicado: (2018) -
Levetiracetam as a First-line Agent for Neonatal Seizure
por: Mandal, Anirban, et al.
Publicado: (2017) -
Role of Levetiracetam in Neonatal Seizure
por: Murty, Yerramilli V.S.S., et al.
Publicado: (2012) -
Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures
por: Maitre, Nathalie L, et al.
Publicado: (2013) -
Experience and pharmacokinetics of Levetiracetam in Korean neonates with neonatal seizures
por: Shin, Jae Won, et al.
Publicado: (2017)